Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.47
Delayed Data
As of Aug 28
 +0.0179 / +3.96%
Today’s Change
0.38
Today|||52-Week Range
0.69
-16.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$76.9M

Company Description

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its lead product MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and thrombosis. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Contact Information

Mast Therapeutics, Inc.
3611 Valley Centre Drive
San Diego California 92130
P:(858) 552-0866
Investor Relations:
18585520866303

Employees

Shareholders

Other institutional9.14%
Mutual fund holders10.73%
Individual stakeholders0.29%

Top Executives

Brian M. CulleyChief Executive Officer & Director
Brandi L. RobertsChief Financial Officer, CAO & Senior VP
Edwin L. ParsleyChief Medical Officer & Senior Vice President
Robert Martin EmanueleSenior Vice President-Development
Gregory D. GorgasSenior Vice President-Commercial